93 related articles for article (PubMed ID: 34602462)
1. Incidental nonfunctioning pancreatic neuroendocrine tumors: Contrast enhanced ultrasound features in diagnosis1.
Yang D; Wang D; Qiu Y; Tian X; Zuo D; Dong Y; Lou W; Wang W
Clin Hemorheol Microcirc; 2022; 80(4):343-352. PubMed ID: 34602462
[TBL] [Abstract][Full Text] [Related]
2. Differential diagnosis between pancreatic solid pseudopapillary tumors and pancreatic neuroendocrine tumors based on contrast enhanced ultrasound imaging features.
Zhang Q; Qiu YJ; Yang DH; Lu XY; Chen S; Dong Y; Wang WP
Clin Hemorheol Microcirc; 2023; 85(4):421-431. PubMed ID: 37718786
[TBL] [Abstract][Full Text] [Related]
3. Nonhypovascular pancreatic ductal adenocarcinomas: CEUS imaging findings and differentiation from other types of solid pancreatic lesions.
Wang L; Nie F; Dong T; Yin C; Li M; Li Y
Clin Hemorheol Microcirc; 2022; 81(2):163-176. PubMed ID: 35253738
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of intravoxel incoherent motion diffusion-weighted imaging for distinguishing nonhypervascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
Zeng P; Ma L; Liu J; Song Z; Liu J; Yuan H
Eur J Radiol; 2022 May; 150():110261. PubMed ID: 35316674
[TBL] [Abstract][Full Text] [Related]
5. Radiomics analysis from magnetic resonance imaging in predicting the grade of nonfunctioning pancreatic neuroendocrine tumors: a multicenter study.
Zhu HB; Zhu HT; Jiang L; Nie P; Hu J; Tang W; Zhang XY; Li XT; Yao Q; Sun YS
Eur Radiol; 2024 Jan; 34(1):90-102. PubMed ID: 37552258
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation.
Kawasaki Y; Hijioka S; Nagashio Y; Maruki Y; Ohba A; Takeshita K; Takasaki T; Agarie D; Hagiwara Y; Hara H; Okamoto K; Yamashige D; Kondo S; Morizane C; Ueno H; Mizui T; Takamoto T; Nara S; Ban D; Esaki M; Tamada K; Hiraoka N; Saito Y; Okusaka T
J Gastroenterol; 2023 Jul; 58(7):693-703. PubMed ID: 37154933
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis.
Yang DH; Cheng J; Tian XF; Zhang Q; Yu LY; Qiu YJ; Lu XY; Lou WH; Dong Y; Wang WP
Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673048
[TBL] [Abstract][Full Text] [Related]
9. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Qiu YJ; Zhao GC; Shi SN; Zuo D; Zhang Q; Dong Y; Lou WH; Wang WP
Clin Hemorheol Microcirc; 2022; 81(2):149-161. PubMed ID: 35253737
[TBL] [Abstract][Full Text] [Related]
10. Long-term Follow-up of Small Nonfunctioning Pancreatic Neuroendocrine Tumors Diagnosed Using Endoscopic Ultrasound-guided Fine-needle Aspiration.
Takano Y; Yamawaki M; Noda J; Azami T; Niiya F; Maruoka N; Yamagami T; Norose T; Ohike N; Nagahama M
Intern Med; 2023 Dec; 62(24):3585-3590. PubMed ID: 37081682
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images.
Dong Y; Yang DH; Tian XF; Lou WH; Wang HZ; Chen S; Qiu YJ; Wang W; Dietrich CF
Br J Radiol; 2023 Sep; 96(1149):20220783. PubMed ID: 37393539
[TBL] [Abstract][Full Text] [Related]
12. Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).
Battistella A; Partelli S; Andreasi V; Marinoni I; Palumbo D; Tacelli M; Lena MS; Muffatti F; Mushtaq J; Capurso G; Arcidiacono PG; De Cobelli F; Doglioni C; Perren A; Falconi M
Surgery; 2022 Oct; 172(4):1236-1244. PubMed ID: 35953308
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic Ultrasound-Guided Therapies in Patients with Pancreatic Neuroendocrine Tumors.
Morgan AD; Ramai D; Bandaru P; Crino SF; Facciorusso A
Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1355-1358. PubMed ID: 37055906
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic ultrasound-guided radiofrequency ablation of premalignant pancreatic-cystic neoplasms and neuroendocrine tumors: prospective study.
Younis F; Ben-Ami Shor D; Lubezky N; Geva R; Osher E; Shibolet O; Phillips A; Scapa E
Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1111-1115. PubMed ID: 36170679
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic ductal adenocarcinoma: CEUS characteristics are correlated with pathological findings and help predict early recurrence after resection.
Wang L; Wang G; Wang P; Nie F
J Clin Ultrasound; 2024; 52(3):230-240. PubMed ID: 38018362
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing pancreatic solid serous cystadenomas from nonfunctional pancreatic neuroendocrine tumors by computed tomography: A propensity score analysis.
Fang X; Jiang H; Cao K; Li J; Liu F; Wang L; Lu J; Shao C; Bian Y
Medicine (Baltimore); 2022 Sep; 101(37):e30523. PubMed ID: 36123910
[TBL] [Abstract][Full Text] [Related]
17. Status of Surveillance and Nonsurgical Therapy for Small Nonfunctioning Pancreatic Neuroendocrine Tumors.
van Beek DJ; Verschuur AVD; Brosens LAA; Valk GD; Pieterman CRC; Vriens MR
Surg Oncol Clin N Am; 2023 Apr; 32(2):343-371. PubMed ID: 36925190
[TBL] [Abstract][Full Text] [Related]
18. Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.
Marx M; Godat S; Caillol F; Poizat F; Ratone JP; Pesenti C; Schoepfer A; Hoibian S; Dahel Y; Giovannini M
Dig Endosc; 2022 Sep; 34(6):1207-1213. PubMed ID: 34963025
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features and long-term prognosis of purely cystic pancreatic neuroendocrine tumors: A single-center experience.
Ren SJ; Wang X; Ke NW; Tan QQ; Yang F; Yao WQ; Tan CL; Liu XB
Asian J Surg; 2023 Feb; 46(2):774-779. PubMed ID: 35850904
[TBL] [Abstract][Full Text] [Related]
20. Comparison of EUS-guided ablation and surgical resection for nonfunctioning small pancreatic neuroendocrine tumors: a propensity score-matching study.
So H; Ko SW; Shin SH; Kim EH; Son J; Ha S; Song KB; Kim HJ; Kim MH; Park DH
Gastrointest Endosc; 2023 Apr; 97(4):741-751.e1. PubMed ID: 36400239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]